Amplia Therapeutics (ASX:ATX) Share Price and News - StockTrack

Market Cap (19-Sep) $61,568,592 (1,444th)	Close (30-Jun) $0.076 0 (0%)	Volume (30-Jun) 120,981	Shortsold (26-May) 11,577 (0.00%) (629th)
52w High $0.425	52w Low $0.056	P/E -	EPS -0.02

	Subject
	ATX ATX Ann: Blueflag Holding - Change of Interest of Substantial Holder
	1 (current) 2 3
	ATX ATX Ann: Application for quotation of securities - ATX
	ATX ATX Ann: Proposed issue of securities - ATX
	ATX ATX Ann: Proposed issue of securities - ATX
	ATX ATX Ann: Capital Raising Investor Presentation
	ATX ATX Ann: Entitlement Offer Prospectus
	ATX ATX Ann: Placement and Underwritten Entitlement Offer to Raise $12.4m
	ATX ATX Ann: Amplia and CRUK agree to Amend Licence Terms - AMP886
	ATX ATX Ann: Trading Halt
	ATX ATX Ann: Quarterly Activities and Cashflow Reports - Sep 2021 Qtr
	ATX ATX Ann: Amplia Appoints New Oncology Clinical Advisor
	ATX ATX Ann: Amplia Provides Updated Investor Presentation
	ATX ATX Ann: Amplia Receives $1.1m R&D Tax Incentive
	ATX ATX Ann: Amplia Appoints New Chief Financial Officer
	ATX ATX Ann: New Garvan Publication Supports Amplia Phase 2 Design
	ATX ATX Ann: Proactive Investors Lifesciences Webinar Presentation
	ATX ATX Ann: Amplia to Present at Proactive Investor Lifesciences Webinar
	ATX ATX Ann: Phase 2 Trial in First-Line Pancreatic Cancer Patients
	ATX ATX Ann: Updated Investor Presentation
	ATX ATX Ann: Change of Director's Interest Notice - Jane Bell
	ATX ATX Ann: Results of Annual General Meeting
	ATX ATX Ann: AGM - Chief Executive Officer's Presentatioin
	ATX ATX Ann: Annual General Meeting Arrangements
	ATX ATX Ann: Quarterly Activities and Cashflow Reports and Presentation
	ATX ATX Ann: Shareholder Update and Presentation
	ATX ATX Ann: App 4G - Key to Corporate Governance Disclosures
	ATX ATX Ann: 2021 Corporate Governance Statement
	ATX ATX Ann: Annual Report to Shareholders - YE 31 March 2021
	ATX ATX Ann: Notice of Annual General Meeting/Proxy Form
	ATX ATX Ann: Results from Successful Phase 1 Clinical Trial of AMP945
	ATX ATX Ann: Financial Report YE 31 March 2021 - Audited
	ATX ATX Ann: Amplia and Garvan Enter Into Collaboration Agreement
	ATX ATX Ann: Annual General Meeting to be Held 27 August 2021
	ATX ATX Ann: Change of Director's Interest - Dr. Lambert Exercise Options
	ATX ATX Ann: Application for quotation of securities - ATX
	ATX ATX Ann: Application for quotation of securities - ATX
	ATX ATX Ann: AMP945 Improves Survival in Pacnreatic Cancer Model
	ATX ATX Ann: Application for Quotation of Shares - Options Exercised
	ATX ATX Ann: App 4E - Preliminary Final Report YE 31 March 2021
	ATX ATX Ann: Change in substantial holding
	ATX ATX Ann: Section 708A Cleansing Notice - Share Placement
	ATX ATX Ann: Appendix 2A - Application for Quotation of Shares
	ATX ATX Ann: Appendix 3G - Notification of Issue of Securties - Options
	ATX ATX Ann: Proposed issue of Securities - ATX
	ATX ATX Ann: Amplia Announces $3.8m Share Placement
	ATX ATX Ann: Trading Halt
	ATX ATX Ann: Preclinical Data Support Developmnt AMP945 Pancreatic Cancer
	ATX ATX Ann: Quarterly Report and Shareholder Update
	ATX ATX Ann: Initial Director's Interest Notice - Jane Bell
	ATX ATX Ann: Shareholder Update and Presentation

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.16	670,399	-0.01 (6.06%)
12-Sep	$0.17	950,489	+0.01 (6.45%)
11-Sep	$0.16	2,961,444	0.00 (0.00%)
05-Sep	$0.16	3,291,458	-0.01 (3.13%)
04-Sep	$0.16	4,182,805	0.00 (0.00%)
03-Sep	$0.16	678,670	-0.01 (3.03%)
29-Aug	$0.17	4,156,208	-0.01 (2.94%)
28-Aug	$0.17	2,347,906	-0.02 (8.11%)
22-Aug	$0.19	1,517,257	0.00 (0.00%)
21-Aug	$0.19	688,959	-0.02 (7.50%)
15-Aug	$0.20	4,600,104	+0.01 (5.26%)
14-Aug	$0.19	2,947,402	+0.01 (2.70%)
07-Aug	$0.19	9,554,622	-0.06 (22.92%)
31-Jul	$0.24	3,939,720	0.00 (0.00%)
30-Jul	$0.24	8,588,868	+0.01 (2.13%)
4 up, 7 down, and 4 flat days

High $0.08	Low $0.07	Trades 8	Turnover $9,058	Volume 120,981
30 June 2023 at 2:59pm

High $0.08	Low $0.07	Trades 8	Turnover $9,058	Volume 120,981
30 June 2023 at 2:59pm

Amplia Therapeutics Health Care

$0.076 -0.001 (-1.30%)

$0.076 -0.001 (-1.30%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices